BlackBerry Ltd:企業のM&A・事業提携・投資動向

◆英語タイトル:BlackBerry Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2332
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

BlackBerry Ltd – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s BlackBerry Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by BlackBerry Ltd since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes BlackBerry Ltd’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by BlackBerry Ltd. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on BlackBerry Ltd’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by BlackBerry Ltd and its subsidiaries since 2007.
- Information about key financial and legal advisors for BlackBerry Ltd’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about BlackBerry Ltd’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 84
Corporate Venturing – Overview 84
Corporate Venturing – Deal reports 85
PARTNERSHIP 87
Partnership – Overview 87
Partnership – Deal reports 88
CAPITAL RAISING 121
Capital Raising – Deal reports 121
DIVESTMENTS 124
Divestments – Overview 124
Divestments – Deal reports 125
PRIVATE EQUITY & OWNERSHIP 132
Private Equity and Ownership – Deal reports 132
APPENDIX 140
Contact Us 140
About MarketLine Financial Deals Database 140
Deal Definition and Methodology 142
About MarketLine 149

List of Tables
Table 1: BlackBerry Limited M&A volume and value trend (2014-YTD2018)
Table 2: BlackBerry Limited M&A activity by geography (2014-YTD2018)
Table 3: BlackBerry Limited corporate venturing volume and value trend (2014-YTD2018)
Table 4: BlackBerry Limited corporate venturing by geography (2014-YTD2018)
Table 5: BlackBerry Limited partnership volume and value trend (2014-YTD2018)
Table 6: BlackBerry Limited partnership trend by key deal type (2014-YTD2018)
Table 7: BlackBerry Limited divestments volume and value trend (2014-YTD2018)
Table 8: BlackBerry Limited divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: BlackBerry Limited M&A volume and value trend (2014-YTD2018)
Figure 2: BlackBerry Limited M&A activity by geography (2014-YTD2018)
Figure 3: BlackBerry Limited corporate venturing volume and value trend (2014-YTD2018)
Figure 4: BlackBerry Limited corporate venturing by geography (2014-YTD2018)
Figure 5: BlackBerry Limited partnership volume and value trend (2014-YTD2018)
Figure 6: BlackBerry Limited partnership trend by key deal type (2014-YTD2018)
Figure 7: BlackBerry Limited divestments volume and value trend (2014-YTD2018)
Figure 8: BlackBerry Limited divestments by geography (2014-YTD2018)

★海外企業調査レポート[BlackBerry Ltd:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Westgold Resources Ltd (WGX):企業の財務・戦略的SWOT分析
    Westgold Resources Ltd (WGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • China International Water & Electric Corp:企業の戦略的SWOT分析
    China International Water & Electric Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Global Blood Therapeutics Inc (GBT):企業の財務・戦略的SWOT分析
    Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment o …
  • R-Biopharm AG:医療機器:M&Aディール及び事業提携情報
    Summary R-Biopharm AG (R-Biopharm), a subsidiary of Rohm Gmbh & Co KG, is a developer of test solutions for clinical diagnostics and food and feed analysis. The company offers test systems in the areas of infectological stool diagnostics, serological infection and allergy diagnostics for clinical di …
  • Numedii Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Numedii Inc (Numedii) is a life science technology company that discovers and develops new drug candidates by translating life sciences big data into therapies. The company uses life sciences big data technology to discover and de-risk molecular entities based on therapeutically relevant bio …
  • Hemispherx Biopharma Inc (HEB):医療機器:M&Aディール及び事業提携情報
    Summary Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chro …
  • Japan Tobacco Inc.:企業の戦略・SWOT・財務分析
    Japan Tobacco Inc. - Strategy, SWOT and Corporate Finance Report Summary Japan Tobacco Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Intra-Cellular Therapies Inc (ITCI):企業の財務・戦略的SWOT分析
    Summary Intra-Cellular Therapies Inc (ICTI) is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurodegenerative diseases. Its pipeline products include lumateperone (ITI-007), used for the treatment of schizophrenia, behavioral disturbances associat …
  • Chimerix Inc (CMRX):企業の財務・戦略的SWOT分析
    Summary Chimerix Inc (Chimerix) is a bio pharmaceutical company that develops, discovers, and commercializes novel and oral antiviral therapeutics. The company’s brincidofovir, an oral nucleotide analog to treat dsDNA viruses, adenovirus, cytomegalovirus, BK virus and herpes simplex viruses. Chimeri …
  • DTE Energy Co (DTE):石油・ガス:M&Aディール及び事業提携情報
    Summary DTE Energy Company (DTE Energy) is a diversified energy company that develops and manages energy-related businesses and services. It has presence in the electricity value chain from generation, procurement, to transmission, distribution, and sales. The company procures, stores, and transport …
  • Parker-Hannifin Corporation:企業の戦略・SWOT・財務情報
    Parker-Hannifin Corporation - Strategy, SWOT and Corporate Finance Report Summary Parker-Hannifin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Dynegy Inc.:戦略・SWOT・企業財務分析
    Dynegy Inc. - Strategy, SWOT and Corporate Finance Report Summary Dynegy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Oneida Ltd.:企業の戦略的SWOT分析
    Oneida Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ascena Retail Group Inc:企業の戦略的SWOT分析
    Ascena Retail Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Enlivant Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Enlivant Inc (Enlivant) is an assisted living facilities provider that offers senior living residence services. The center provides senior housing options, choosing assisted living and short term stay services. It also provides attentive and individualized care services. Enlivant offers assi …
  • Health Net Inc:企業の戦略的SWOT分析
    Health Net Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Melinta Therapeutics Inc (MLNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Melinta Therapeutics Inc (Melinta) is a biopharmaceutical company that focuses on the development of novel antibiotics. Its drugs are intended to treat the various bacterial infections. The company's lead product Baxdela (delafloxacin) has been approved by the US FDA as an IV treatment for s …
  • Aliaxis S.A.:企業の戦略・SWOT・財務情報
    Aliaxis S.A. - Strategy, SWOT and Corporate Finance Report Summary Aliaxis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Siemens Healthineers.:企業のM&A・事業提携・投資動向
    Siemens Healthineers. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Siemens Healthineers. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Li & Fung Limited:企業の戦略・SWOT・財務情報
    Li & Fung Limited - Strategy, SWOT and Corporate Finance Report Summary Li & Fung Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆